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S U M M A R Y
Objective: To assess the seroprevalence of hepatitis B virus (HBV), syphilis, and HIV and associated risk
factors in pregnant women and their male partners from six indigenous populations of the Peruvian
Amazon Basin.
Methods: A cross-sectional study was performed in six indigenous populations from the Peruvian
Amazon Basin. Blood samples were obtained and tested for HBV (antibodies to the hepatitis B core
antigen (anti-HBc) and hepatitis B surface antigen (HBsAg)), for syphilis (rapid plasma reagin and
microhemagglutination assay for Treponema pallidum antibodies), and for HIV (ELISA and indirect
immunoﬂuorescence test). A survey was also performed to identify associated risk factors.
Results: One thousand two hundred and ﬁfty-one pregnant women and 778 male partners were enrolled
in the study. The seroprevalence of anti-HBc in pregnant women was 42.06% (95% conﬁdence interval
(CI) 39.28–44.85%) and in their male partners was 54.09% (95% CI 50.32–57.86%). The seroprevalence of
HBsAg in pregnant women was 2.11% (95% CI 0.78–3.44%) and in their male partners was 3.98% (95% CI
1.87–6.08%). The seroprevalence of syphilis in pregnant women was 1.60% (95% CI 0.86–2.33%) and in
their male partners was 2.44% (95% CI 1.22–3.66%). HIV seroprevalence in pregnant women was 0.16%
(95% CI 0.02–0.58%) and in their male partners was 0.29% (95% CI 0.04–1.03%). Sexual risk factors were
strongly related to blood markers of syphilis and HBV.
Conclusions: Hepatitis B was found to be hyperendemic and strongly related to sexual factors, suggesting
an important sexual component in the transmission of the disease in the populations studied. Syphilis
was found to have an endemicity in pregnant women above the national level and this may be indicative
of high mother-to-child transmission. HIV has started to show its presence in indigenous populations of
the Amazon Basin and the results suggest the epidemic is concentrated.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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HIV, Treponema pallidum (the etiologic agent of syphilis), and
hepatitis B virus (HBV) produce three infectious diseases, and their
main routes of transmission are sexual intercourse, parenteral
transmission, and vertical (mother-to-child) transmission. Hori-
zontal transmission of HBV is also very important, especially in
areas of high prevalence.1–3
HBV is the major cause of chronic infection in the world, with
more than 350 million people chronically infected. The World
Health Organization (WHO) estimates that approximately 600 000* Corresponding author. Tel.: +51 1 4614307; fax: +51 1 4614347.
E-mail addresses: mormaeche@dge.gob.pe, mormaeche@gmail.com
(M. Ormaeche).
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http://dx.doi.org/10.1016/j.ijid.2012.05.1032people die annually as a result of HBV infections, including
hepatocellular carcinoma and cirrhosis.3 In Latin America, the
endemicity of HBV varies between countries with a seroprevalence
of antibodies to the hepatitis B core antigen (anti-HBc) in urban
populations ranging from 0.6% in Chile to 21.4% in the Dominican
Republic.4 In South America, 100 000 people are infected each year,
and estimations show that it is responsible for 25–67% of all
chronic hepatitis B cases and 10–70% of all primary hepatocellular
carcinoma cases.5 Even though estimations show that the level of
HBV endemicity in our region is low, these same estimations point
to the Amazon Basin, shared by Bolivia, Brazil, Colombia, Ecuador,
French Guyana, Guyana, Peru, Suriname, and Venezuela, as an area
of high endemicity.4,5
Estimations made for year 2009 show that 2.6 (2.3–2.8) million
people became infected with HIV, with 92 000 of the infections
occurring in Central and South America, accounting for ases. Published by Elsevier Ltd. All rights reserved.
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areas. Over the last 20 years of the epidemic, the seroprevalence of
HIV has remained stable in the countries of the region, with a
tendency towards a rise in the number of people living with HIV
due to increased access to highly active antiretroviral therapy
(HAART).2 In Peru, the HIV epidemic is considered to be
concentrated. Evidence shows the seroprevalence of HIV to have
remained consistently under 0.5% in the general population but
over 5% in high-risk populations.1,6 HIV cases are mostly located in
urban areas of the coast and jungle (Amazon) geographic
regions,1,7 and are particularly concentrated in high-risk groups
such as men who have sex with men (MSM).1,8,9
The prevalence of syphilis in Peru is considered to be 0.5% in
men and 1.0% in women,10 although a large study in Lima City
found a seroprevalence of 1.6% in pregnant women.6 Nevertheless,
available data principally reﬂect the situation of HIV and syphilis in
urban areas, where most cases are detected. In small populations,
even a small number of cases might pose a serious public health
problem, especially if cases occur in highly vulnerable populations.
Forty-two indigenous populations live in the Peruvian Amazon
jungle, each with its own cultural characteristics and with its own
social and economic structures. Within these populations, health is
considered in a holistic way, because it expresses dynamic
relationships between the individual and the collective, the
natural and social environments. These populations are highly
vulnerable to health problems, due to a lack of access to health
services, mainly because of an inadequate health offer, the
disarticulation of their knowledge of traditional/natural medicine,
and to the small size and dispersion of their populations.11–15
Scientiﬁc investigations carried out in indigenous populations of
the Amazon have found a high seroprevalence of HBV in Peru.16–18
Nevertheless, none of these studies have identiﬁed risk factors
associated with HBV or with the seroprevalence in speciﬁc
population groups. Also, reports of AIDS cases in Amazon
indigenous populations began to appear in 2004. In 2007, a high
seroprevalence was reported in an indigenous population located
in a peri-urban area of the district of Yurimaguas in the province of
Alto Amazonas, in Loreto Region.19 Nevertheless the study
comprised a small indigenous population located in a peri-urban
area, and speciﬁc population groups were not addressed.
This situation is occurring within an international context in
which the Pan American Health Organization and the WHO are
promoting an initiative to eliminate the vertical transmission of
HIV and syphilis in the Americas and the world.20 Studying
indigenous pregnant women and their male partners would allow
sexually active population groups to be examined, which is key to
understanding both the sexual and vertical transmission of HIV,
syphilis, and HBV. Therefore the objective of this study was to
identify the seroprevalence and factors associated with HBV,
syphilis, and HIV in pregnant women and their male partners from
six indigenous populations of the Peruvian Amazon Basin.
2. Methods
A cross-sectional study was performed between July 16, 2007
and June 16, 2008. Six of the 42 indigenous populations that reside
in the Peruvian Amazon were selected by means of convenience
sampling regarding their ease of access, population size, and area
of residence: Kandozi, Shapra, Shiwilo (Chayahuita), Matsigenka,
Ashaninka, and Shipibo Konibo. They are located in the political
regions of Loreto, Ucayali, Cusco, Junı´n, and Pasco. The study
population constituted pregnant women and their current sexual
partners from the six indigenous populations selected.
In Loreto Region, all the native communities of the Kandozi,
Shapra, and Shiwilo populations were included in the study. In
Ucayali, all the communities of the Shipibo Konibo populationwere included (although there are some communities in Loreto,
the main numbers are located in Ucayali). In Cusco, all Matsigenka
communities were included. In Junı´n and Pasco, all Ashaninka
communities were included. The Ashaninka make up the largest
indigenous population in the Amazon jungle, and as well as living
in Junı´n and Pasco, they also reside in Hua´nuco and Ucayali, and a
small number reside in Loreto. A communal census was performed
in each indigenous community in order to identify all pregnant
women and their male sexual partners, and all were invited to
participate in the study. All pregnant women or their male partners
who did not give their informed consent were excluded from the
study, as well as those without the capacity to provide this.
HIV infection was detected using a fourth-generation ELISA as the
screening test and an indirect immunoﬂuorescence test (IIFT) as the
conﬁrmatory test. Two tests were performed for the detection of
syphilis, the rapid plasma reagin (RPR) test as the screening test and
a microhemagglutination assay for Treponema pallidum antibodies
(MHA-TP) as the conﬁrmatory test. Finally, ELISA tests for anti-HBc
and hepatitis B surface antigen (HBsAg) were performed. Blood
samples were obtained by venous puncture in the forearm, drawing
a quantity of 7 cm3. Serum samples were obtained directly in the
ﬁeld and were maintained in a cold chain (2–8 8C) until arrival at the
regional laboratories at which the ELISA tests for HIV and anti-HBc,
RPR, and MHA-TP tests were performed. Samples positive for HIV
were sent to the National Institute of Health for conﬁrmation by IIFT.
Also, samples positive for anti-HBc were sent to the Regional
Laboratory of the South Lima Health Department where samples
were also tested using an ELISA for HBsAg. Even though kits from
different producers were used at each laboratory, all complied with
the standardized technical speciﬁcations provided by the National
Institute of Health (http://www.ins.gob.pe/ﬁchasins/default.asp).
A survey was also administered to identify risk behaviors,
following the Joint United Nations Programme on HIV/AIDS
(UNAIDS) recommendations. The survey was reviewed by theme
experts and by indigenous leaders during a workshop with the
participation of the Asociacio´n Intere´tnica de Desarrollo de la Selva
Peruana (AIDESEP), which is the national organization of the
indigenous populations residing in the Peruvian Amazon.
Hepatitis B endemicity was considered to be low when chronic
infection was less than 2% or anti-HBc less than 15%; intermediate
when chronic infection was 2–7% or anti-HBc prevalence ranged
from 15% to 40%; and high when chronic infection was over 7% or
anti-HBc prevalence was over 40%.
Syphilis seroprevalence was considered to be high in pregnant
women and their male partners if it was above the national mean
estimations. The Action Plan for Congenital Syphilis Elimination
states that to achieve the objective of eliminating congenital
syphilis, more than 95% of pregnant women with syphilis should
be identiﬁed and treated, and that syphilis seroprevalence during
pregnancy should be reduced to below 1%.21
HIV seroprevalence was evaluated using the World Bank/
UNAIDS/WHO criteria for a low level epidemic, concentrated
epidemic, and generalized epidemic.
Study teams were formed in all political regions. These teams
consisted of health professionals from the departments of
epidemiology and health services and the laboratories, who
worked in conjunction with the organizations representing the
indigenous populations participating in the study. Workshops
were conducted with these teams and the organizations repre-
senting the indigenous populations to plan ﬁeld activities. Local
teams were strengthened by inﬁrmary professionals and intercul-
tural facilitators of both sexes.
Local teams visited the study area three times. The ﬁrst visit was
to present the study to the local authorities in all communities of
the selected populations, and to obtain their authorization to begin
the study. Also a census was conducted to identify all pregnant
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identiﬁed in this census were invited to join the study. The second
visit was done to obtain informed consent from the participants, to
collect the serum samples, and to carry out the survey. Prior to
obtaining serum samples, pretest counseling was done following
the norms of the National Strategy for HIV Control and Prevention.
The third visit was done to deliver the test results individually and
in conﬁdentiality. As part of this process, personal post-test
counseling was delivered.
The statistical analysis was performed using SPSS v. 13 (IBM
Corp., NY, USA) and Epidat v. 3.1 (Direccio´n Xeral de Sau´de Pu´blica,
Consellerı´a de Sanidade – Xunta de Galicia, Espan˜a; Organizacio´n
Panamericana de la Salud, Washington DC, USA). Conﬁdence
intervals (95% CI) were calculated for seroprevalence data. Odds
ratios (OR) and the Chi-square test were used to test statistical
associations for qualitative variables; the Student’s t-test and the
Mann–Whitney U-test were used for quantitative variables. For the
multivariate analysis, a binary logistic regression test was used,
applying a manual entry method, in order to identify the risk
factors associated with anti-HBc positivity. A total of 32 variables
exploring socioeconomic status, sexual behavior and parity, and
past history of sexually transmitted infections (STIs) and
knowledge on prevention were ﬁrst included in the analysis. Only
those showing signiﬁcance at the 5% level were kept.
The study project was reviewed and approved by an ethics
committee. For this study, authorization was solicited and
obtained from the indigenous population authorities at the
national, regional, and local levels. Also, individual written consent
was obtained from all participants before applying the survey and
obtaining the blood samples. Pre-test and post-test counseling was
delivered to all participants, and the results of all their tests were
delivered to them in privacy, according to the State Law
CONTRASIDA 26626 of our country. Action was taken to ensure
that all patients who tested positive had access to treatment
provided by the government health services. All processes were
carried out with the indigenous authorities present in order to
conduct the study in a proper cultural way. Also, male and female
translators accompanied the survey teams.
3. Results
A total of 1633 pregnant women were identiﬁed, of whom 1251
agreed to participate in the study. Seven hundred and seventy-
eight of their male partners also agreed to participate. All serum
samples from the pregnant women were tested for HIV and
syphilis, and 1241 for HBV. For male partners, 697 serum samples
were tested for HIV, syphilis, and HBV.
Table 1 shows the seroprevalence results. Two HIV cases were
detected in pregnant women and two in male partners. One
positive male was the sexual partner of an HIV-positive pregnantTable 1
Seroprevalence of serum markers for HIV, syphilis, and hepatitis B in pregnant women
Variable Pregnant women 
n/N Prevalence (%) 95% CI 
HIV
Elisa/IFFT 2/1251 0.16 0.02–0.58 
Syphilis
RPR/MHA-TP 20/1251 1.60 0.86–2.33 
Hepatitis B
Anti-HBc 522/1241 42.06 39.28–44.85 
HBsAg 11/522 2.11 0.78–3.44 
95% CI, 95% conﬁdence interval; IFFT, indirect immunoﬂuorescence test; RPR, rapid p
antibodies; anti-HBc, antibodies to the hepatitis B core antigen; HBsAg, hepatitis B sur
a Chi-square test.
b Fisher’s exact test.woman. The other positive male was the partner of an HIV-
negative pregnant woman. The male partner of the other HIV-
positive pregnant women did not agree to participate in the study.
HBV anti-HBc seroprevalence results for each indigenous
population included in the study are presented in Table 2.
The mean age of the pregnant women was 25.1 years (standard
deviation (SD) 7.1 years) and of their male partners was 29.8 years
(SD 8.6 years). The percentage of pregnant women without a
formal education was 10.6% (129/1215) and for their male partners
this was 5.5% (40/730; p < 0.001). Pregnant women achieved a
lower level of education compared to males (p < 0.001), with a
higher percentage attaining basic/elementary education (61.2% vs.
46.6%) and a lower percentage attaining a high school education
(27.2% vs. 42.2%) or college education (1.0% vs. 5.7%).
The main economic activities of the indigenous pregnant
women were housework (55.7%; 693/1244) and subsistence
agriculture (41.6%; 517/1244). The main male economic activity
was agriculture (87.7%; 682/778). Also, male partners had greater
access to other productive activities like working in the education
sector (3.0% vs. 0.2%) and in local government (1.1% vs. 0.1%).
The mean number of pregnancies was 3.9 (SD 2.7) and the mean
number of living children was 2.7 (SD 2.3). Pregnant women were
younger at sexual initiation when compared to their male partners
(14.9 years, SD 2.4 vs. 16.1 years, SD 2.7; p < 0.001). The mean
number of sexual partners during their lifetime was lower for
pregnant women compared to their male partners (2.3 vs. 8.6,
p < 0.001), as well as the mean number of sexual partners other than
their ofﬁcial sexual partner in the 12 months prior to the survey (0.16
vs. 1.72, p < 0.001) and in the 3 months prior to the survey (0.10 vs.
1.85, p < 0.001). Fewer pregnant women than their male partners
reported having had sexual contact with people other than their
partner during the 12-month period (10.6% vs. 27.6%, p < 0.001) and
3-month period (6.5% vs. 14.5%, p < 0.001) before the survey. More
than a ﬁfth (21.4%; 250/1168) of the pregnant women believed their
partners to have been unfaithful to them: with other indigenous
women (87.2%), female sex workers (7.6%), or MSM (0.8%); 4.4%
were not able to identify with whom their partner had been
unfaithful. Of the pregnant women, 12.6% (158/1251) reported
having received treatment for STIs; 9.4% (118/592) of their male
partners reported treatment for STIs. Even though 41.1% (502/1221)
of the pregnant women and 70.6% (480/680) of their male partners
recognized that using condoms is an effective method to prevent the
transmission of STIs, only 13.8% (170/1228) and 28.7% (197/687),
respectively, reported having used one at some time. Further, only
12.0% (76/634) of the male partners reported using one with the
pregnant women. Only 2.6% (32/1228) of the pregnant women and
5.5% (38/687) of male partners reported always using a condom.
The assessment of STI transmission knowledge among 687
pregnant women and 568 male partners showed that 76.4% and
79.0%, respectively, identiﬁed sexual contact as an important and their male partners from six indigenous Amazon populations in Peru
Male partners p-Valuea
n/N Prevalence (%) 95% CI
2/697 0.29 0.04–1.03 0.554b
17/697 2.44 1.22–3.66 0.202
377/697 54.09 50.32–57.86 0.002
15/377 3.98 1.87–6.08 0.109
lasma reagin test; MHA-TP, microhemagglutination assay for Treponema pallidum
face antigen.
Table 2
Anti-HBc seroprevalence by indigenous population
Variable Pregnant women Male partners
n Prevalence (%) n Prevalence (%)
Populations n = 1237 n = 663
Ashaninka 212/728 29.1 147/351 41.9
Kandozi 18/18 100 12/12 100
Shapra 36/36 100 21/21 100
Shiwilo 35/94 37.2 38/69 55.1
Matsigenka 84/180 46.7 47/87 54.0
Shipibo Konibo 130/176 73.9 88/109 80.7
Mestiza* 4/5 80 11/14 78.6
Anti-HBc, antibodies to the hepatitis B core antigen.
* Mestiza: non indigenous people married to indigenous men or women.
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17.3% of male partners identiﬁed having multiple sexual partners
as a risk factor for STIs. Even less, 6.4% and 7.2% of pregnant women
and male partners, respectively, recognized sexual contact with
strangers as a risk factor for STIs. Having one sexual partner was
the behavior most frequently recognized as a preventive measure
against STIs: 64.0% (424/663) of pregnant women and 69.0% (387/
561) of their male partners identiﬁed this correctly. Condom use
was the second most frequently identiﬁed preventive measure,
reported by 22.8% (151/662) of pregnant women and 23.9% (134/
561) of their male partners.
Due to the limited number of HIV cases it was not possible to
identify factors associated with this infection. A similar situation
occurred with cases positive for HBsAg. Bivariate and multivariate
analysis was performed for syphilis and anti-HBc markers for both
pregnant women and their male partners.
3.1. Factors associated with syphilis
Logistic regression analysis showed that syphilis positivity in
pregnant women was associated only with syphilis in their male
partners (Table 3). Bivariate analysis showed that the risk factors of
sexual contact with strangers (OR 5.23, 95% CI 2.10–13.02,
p = 0.001) and a vaginal secretion episode during their lifetime
(OR 2.90, 95% CI 1.11–7.60, p = 0.030) were also associated with
syphilis positivity in pregnant women; knowledge of any
preventive measure (OR 0.09, 95% CI 0.01–0.79, p = 0.027) played
a protective role. Male partner risk factors associated with syphilisTable 4
Factors associated with syphilis in male partners of indigenous pregnant women
Model Coefﬁcient 
Point estimation Standa
Syphilis in pregnant woman 2.47 0.90 
Male sexual contact with MSM in last 12 months 2.56 0.79 
Male with 11 sexual partners during lifetime 1.26 0.59 
Male aged 39 years 1.29 0.61 
95% CI, 95% conﬁdence interval; MSM, men who have sex with men.
Table 3
Factors associated with syphilis in indigenous pregnant women
Model Coefﬁcient 
Point estimation Standard error 
Syphilis in male partner 2.32 0.83 
95% CI, 95% conﬁdence interval.in pregnant women were sexual contact with other women (OR
2.50, 95% CI 1.01–6.17, p = 0.053), genital discomfort episode
during lifetime (OR 4.80, 95% CI 1.19–19.40, p = 0.024), and genital
itching episode during lifetime (OR 8.53, 95% CI 1.63–44.69,
p = 0.038).
Logistic regression analysis showed that syphilis in male
partners was associated with syphilis positivity in pregnant
women, and with sexual contact with MSM, having 11 sexual
partners in their lifetime, and being 39 years of age (Table 4).
Bivariate analysis also showed other variables to be associated
with syphilis in male partners: pregnant women factors were age
over 25 years (OR 3.05, 95% CI 1.06–8.76, p = 0.030), working as an
artisan (OR 5.88, 95% CI 1.23–28.01, p = 0.062), sexual contact with
strangers (OR 6.22, 95% CI 2.29–163.87, p = 0.001), and vaginal
secretion (OR 3.33, 95% CI 1.19–9.35, p = 0.031); male partner
factors were sexual initiation with a woman (OR 0.09, 95% CI 0.02–
0.46, p = 0.022), sexual initiation with an MSM (OR 14.04, 95% CI
1.38–142.43, p = 0.095), sexual contact with an MSM in the 12
months prior to the survey (OR 13.66, 95% CI 3.40–54.81,
p = 0.003), genital discomfort (OR 6.44, 95% CI 1.99–20.86,
p = 0.001), and having received treatment for an STI (OR 5.41,
95% CI 2.04–14.36, p = 0.001).
3.2. Factors associated with HBV
Logistic regression analysis showed that anti-HBc positivity in
pregnant women was associated with age at pregnancy and age at
sexual initiation <16 years in the women, and with anti-HBc
positivity, sexual contact with MSM during lifetime, and condom
use in their male partners (Table 5).
For the male partners, logistic regression analysis showed anti-
HBc positivity was associated with anti-HBc positivity in the
pregnant women and sexual initiation of the women before 16
years of age, and to male partner’s age and sexual contact with
MSM during their lifetime (Table 6).
4. Discussion
This is the largest study in the indigenous populations of the
Amazon Basin in Peru to be published and the ﬁrst to address
pregnant women, their male partners, and their sexual habits.
HIV seroprevalence was low in both the pregnant women and
their male partners, although it was higher in male partners than inOdds ratio
rd error p-Value Point estimation 95% CI
Lower limit Upper limit
0.006 11.85 2.03 69.28
0.001 12.93 2.77 60.43
0.033 3.52 1.11 11.18
0.035 3.62 1.10 11.92
Odds ratio
p-Value Point estimation 95% CI
Lower limit Upper limit
0.005 10.19 2.01 51.55
Table 5
Factors associated with anti-HBc in indigenous pregnant women
Model Coefﬁcient Odds ratio
Point estimation Standard error p-Value Point estimation 95% CI
Lower limit Upper limit
Woman’s age at pregnancy 0.06 0.02 <0.001 1.06 1.03 1.09
Woman’s age at sexual initiation <16 years 0.62 0.26 0.018 1.86 1.11 3.11
Male anti-HBc-positive 1.92 0.20 <0.001 6.85 4.60 10.18
Male sexual contact with MSM 1.18 0.47 0.012 3.24 1.29 8.12
Male condom use 0.55 0.22 0.014 0.58 0.38 0.90
Anti-HBc, antibodies to the hepatitis B core antigen; 95% CI, 95% conﬁdence interval; MSM, men who have sex with men.
Table 6
Factors associated with anti-HBc in male partners of indigenous pregnant women
Model Coefﬁcient Odds ratio
Point estimation Standard error p-Value Point estimation 95% CI
Lower limit Upper limit
Anti-HBc in pregnant woman 1.80 0.22 0.000 6.07 3.97 9.28
Woman’s age at sexual initiation <16 years 0.99 0.28 0.000 2.68 1.55 4.64
Male sexual contact with MSM 0.95 0.46 0.036 2.60 1.06 6.35
Male age 0.04 0.01 0.002 1.04 1.02 1.07
Anti-HBc, antibodies to the hepatitis B core antigen; 95% CI, 95% conﬁdence interval; MSM, men who have sex with men.
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was not statistically signiﬁcant. Also, the small number of cases
limited the possibility of determining associations. HIV seroprev-
alence reports in indigenous populations are uncommon. Zavaleta
et al. found an HIV seroprevalence of 7.5% in 80 adults of a native
community of the Chayahuita (Shiwilo) indigenous population
living in a peri-urban area in Loreto Region.19 In 2006 Bartlett et al.
found two HIV cases in 282 people from four indigenous
communities of the same Chayahuita population, but located at
a greater distance from the urban areas.22 Our study, with a larger
sample, from communities located 4–48 h by speedboat from
urban areas, found a lower seroprevalence. This lower seropreva-
lence is closer to that reported from Brazil by Machado et al., who
found an HIV seroprevalence of 0.6% in the Tiriyo tribe of the
Brazilian Amazon Region.23
Some other studies involving non-indigenous Peruvian preg-
nant women have been published. In 1996–1997 Alarcon et al.
found an HIV seroprevalence of 0.5% in pregnant women from Lima
City.6 In 2002 and 2005 the Direccio´n General de Epidemiologı´a
(DGE) found an HIV seroprevalence of 0.21% (95% CI 0.13–0.30%)
and 0.23% (95% CI 0.10–0.50%) in pregnant women from selected
urban areas of the country (DGE, unpublished data). Also, in 2003–
2004 Clark et al. found an HIV seroprevalence of 0.8% (95% CI 0.5–
1.4%) in male partners in four cities of Peru.24 Similar to those
studies, the HIV seroprevalence found in our study was under 1%
and was higher in males than in pregnant women. These results
suggest that the HIV epidemic in the studied populations may be at
the low or concentrated level;1 nevertheless it is still necessary to
identify the HIV prevalence in high-risk groups to determine the
epidemic level. In the study of Zavaleta et al. up to 44.7% of men
admitted sexual contact with other men. Also three of the four self-
identiﬁed MSM in that community were infected with HIV.19
Bartlett et al. found two HIV cases in 135 men; of the 126 men who
answered the question, 39.7% admitted having homosexual
contact at least once. Both positive cases were in this latter
group.22 In 2007, in another study in the Chayahuita population of
the same area, the DGE found three HIV cases in 44 men (6.4%) who
admitted having at least one homosexual contact during their
lifetime (DGE, unpublished data). In the present study, 47 of 756
men (6.2%) admitted having homosexual contact at least once, butnone were HIV-positive. It is worth mentioning that while
conducting the study, HIV testing was offered to 15 indigenous
MSM who were not in the study population; ﬁve of them (33.3%)
were found to be HIV-positive. Even though a larger study with a
better structured sample is needed to reach a conclusion on HIV
prevalence in indigenous MSM, the available evidence suggests
that the HIV epidemic may be at a concentrated level in the
Amazon indigenous population.
The seroprevalence of syphilis was 1.60% in pregnant women
and 2.44% in their male partners, but the difference was not
statistically signiﬁcant. The seroprevalence of syphilis in pregnant
women of 1.60% found in our study is above 1% and may be
indicative of a high risk of mother-to-child transmission.21
Seroprevalences were higher than national estimates,10,21 but
lower than other reports in indigenous populations. Zavaleta et al.
found a syphilis prevalence of 6.3% in a small sample of adult
individuals of the Chayahuita (Shiwilo) indigenous population,
whose males reported having a high frequency of homosexual
contact (44.1%).19 Bartlett et al. found a seroprevalence of syphilis
in males of 3.7% for whom self-reported MSM activity was also
high (39.7%).22 The difference with our study results may be
explained by the frequency of MSM activity and the ease of access
to urban areas. In the present study, when analyzing the factors
associated with syphilis in males, MSM contact in the last 12
months was strongly related, but the frequency of MSM contact
was signiﬁcantly lower than in the studies of Zavaleta et al. and
Bartlett et al.: 6.2% during lifetime and 2.1% in the last 12 months.
Also the frequency of MSM contact varied between the indigenous
groups included in the study. MSM activity was highest in Shipibo
Konibo males with 29.8% during lifetime and 11.7% in the last 12
months; also 14 of 17 conﬁrmed cases of syphilis found in the
study belonged to this indigenous group, with a seroprevalence of
12.4%. The other three cases were Matsigenka males, with a
seroprevalence of 3.3%. The association between syphilis and MSM
activity has also been observed in urban areas of the Peruvian coast
by Snowden et al.10 These results suggest that sexual behavior and
health risks associated with it may vary importantly between
different indigenous populations and even between communities
from the same groups. The distance to urban areas may be another
factor related to differences in syphilis prevalence. Bartlett et al.
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the seroprevalence of syphilis was almost halved in the study of
Bartlett et al. whose sample was obtained from indigenous
communities located at a greater distance from urban areas than
that included in the Zavaleta et al. study. This is also consistent
with our study in which the communities of the six indigenous
populations were located 4–48 h by small speedboat from urban
areas. The distance to urban areas may be working as an indicator
of access to these areas.
Syphilis seroprevalence in both groups was also higher when
compared to the results of other studies of pregnant women and
their partners in urban areas. A study performed by the DGE in 2002
found syphilis seroprevalences in pregnant women of 0.6% in urban
areas of the coast natural region and 0.9% in urban areas of the jungle
(Amazon) natural region (DGE, unpublished data). In male partners
of pregnant women, Clark et al. found a syphilis seroprevalence of
1.6% (95% CI 1.0–2.2%) in urban areas of the coast region,24 which is
lower than the seroprevalence found in this study. The higher
prevalence in indigenous pregnant women and male partners may
also be the result of poor access to health services and treatment
when compared to those living in urban areas.
Other risk factors associated with syphilis in males were 11
sexual partners during their lifetime and male age 39 years. In
agreement with this Clark et al. found that syphilis infection was
associated with 10 sexual partners during their lifetime in urban
areas of the Peruvian coast.24 For pregnant women the only
variable associated with syphilis in the logistic regression analysis
was the presence of syphilis in their male partners. Probably the
small number of positive cases may have limited the power of the
study to ﬁnd other associated factors. All these results may indicate
that the syphilis infection is being introduced into the studied
indigenous populations by indigenous males who make contact
with high-risk groups in urban areas.
The study results were also indicative of a high prevalence of
HBV in the indigenous groups studied. Even though HBsAg
seroprevalences in pregnant women and their male partners were
under 8%, the anti-HBc seroprevalence was over 40% (42.06% and
54.09%, respectively), a situation that conﬁrms the results of other
studies in similar populations.4,5,16–18,25–29
Although it is well known that the main route of transmission of
HBV in areas of high prevalence is perinatal, from mother to child, or
from person to person during early childhood,3 our study identiﬁed
sexual characteristics associated with anti-HBc in pregnant women
and in their male partners, suggesting that sexual transmission
could play an important role even in populations where endemicity
is high. Of the ﬁve factors associated with anti-HBc in pregnant
women, four were related to sexual habits, like sexual initiation
before 16 years of age for the women, male partner positive for anti-
HBc, male partner with homosexual contact, and male partner
condom use. Age was the other variable associated with anti-HBc in
pregnant women, showing an increment of 6% in the probability of
being positive for each year of age. For the male partners, anti-HBc
positivity was associated with the presence of anti-HBc in the
pregnant women and women’s sexual initiation before 16 years of
age, and to male sexual contact with MSM. Age of the male partners
was also related to anti-HBc positivity, with an increment of 4% for
each year of age added.
Other studies in Amazon indigenous populations from other
countries have also identiﬁed low or intermediate levels of HBsAg,
suggesting that apart from vertical transmission, sexual transmis-
sion and household cultural habits –like feeding small children
with food previously chewed by the mothers – may play an
important role in the transmission of HBV in indigenous
populations.25–29 El Khouri et al. found similar results in non-
indigenous populations from urban and rural areas of the Amazon,
with anti-HBc and HBsAg seroprevalences of 40.74% and 2.88%,respectively.30 de Paula et al., also in non-indigenous populations
from urban and rural areas of the Amazon in Brazil, found an anti-
HBc seroprevalence of 66.2%, identifying age and sexual activity as
related factors.31 All these results suggest that in populations of
high endemicity and low HBsAg seroprevalence, sexual transmis-
sion may be the transmission route responsible for the majority of
the cases in the community.
The anti-HBc seroprevalence found in our study conﬁrms the
wide dissemination of HBV in the indigenous populations living in
the Peruvian Amazon Basin, which represents a high risk for
hepatitis B chronic disease in an area characterized by a weak
health system and extreme poverty. Previous studies in Peruvian
Amazon indigenous populations have identiﬁed hepatitis B as a
main cause of mortality and potential years of life lost (PYLL).11–15
Therefore, careful assessment of the hepatitis B situation by the
health authorities is needed in these populations to implement
appropriate control measures.
Our study has limitations. Different ELISA tests were used;
however standardized criteria for sensitivity and speciﬁcity
recommended by the National Institute of Health were used for
their acquisition. Also the tests were performed at each regional
laboratory, which may have introduced a bias in the measurement
of the main variables that is difﬁcult to estimate. Nevertheless,
personnel in these laboratories have been trained in performing
the tests used in this study. The sampling method used limited the
ability to represent the study population, especially since only
some of the Ashaninka and Shipibo Konibo pregnant women and
male partners were included. The number of male partners who
agreed to participate in the study was smaller than expected,
which may have introduced a selection bias and may have affected
the power of the study to identify associations and to make proper
estimations for this group. Regrettably no data were obtained from
the missing male partners making it very difﬁcult to estimate how
their absence may have biased the study results. Face to face
interviewing may also have introduced an information bias both in
women and their male partners, even though they were
interviewed separately and by people of the same sex; this may
have produced an underreporting of culturally reproved behaviors.
The number of pregnant women who answered the questions
related to knowledge of transmission and prevention of the
diseases was approximately half of the total number of surveyed
women, which may have introduced a selection bias in these areas.
When we analyzed the population that chose not to answer these
questions, we found that 62.9% (338/537) had an incomplete
elementary/primary education level or had attained no formal
education level at all, while 60.2% (408/678) of the group that
answered the questions had a complete elementary school or
higher level of education, indicating that knowledge on these areas
may be even lower than observed.
The results of our study express an elevated vulnerability of the
indigenous populations to these diseases. In the case of the HIV
epidemic this may lead to a faster progression than has been
observed in the urban areas of the country where the epidemic has
reached a stabilization point and is focused on groups with high-
risk sexual habits.1,2 The seroprevalence of syphilis in the
indigenous pregnant women is indicative of a high congenital
syphilis prevalence.21,32 HBV has a wide distribution in the
indigenous populations studied and may represent a serious risk
for their survival, especially in the smallest groups, with a very
important sexual-related transmission. To overcome this situation,
prevention and control strategies should be developed and
adapted to an intercultural framework; these should be based
on successful experiences in similar populations.
Recently a new strategy to prevent and control HBV has been
developed, providing treatment for HBV to the Kandozi and Shapra
indigenous populations. This effort should be expanded to take in
M. Ormaeche et al. / International Journal of Infectious Diseases 16 (2012) e724–e730e730HIV and syphilis prevention and control, and should be com-
plemented with an intercultural prevention framework. These
initiatives should be extended promptly to reach all the other
indigenous populations in the Peruvian Amazon.
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